Upgrade to Pro — share decks privately, control downloads, hide ads and more …

microfluidics based chemical separation and rea...

microfluidics based chemical separation and reaction schemes

... talk given at Xi'an. 3rd International Symposium on Instrumentation Science and Technology, ISIST, August 18-22, 2004

andreas manz

August 18, 2004
Tweet

More Decks by andreas manz

Other Decks in Science

Transcript

  1. Microfluidics based chemical Microfluidics based chemical separation and reaction schemes

    p Andreas Manz Andreas Manz I S A S INSTITUTE FOR ANALYTICAL SCIENCES I S A S INSTITUTE FOR ANALYTICAL SCIENCES Dortmund and Berlin
  2. l tit l h i t id tif analytitcal chemistry

    = identify and quantify molecules and quantify molecules •human genome 3,000,000,000 bases g , , , •proteomics > 100,000 different proteins •metabolomics > 10,000,000 different . small molecules •target: single cell analysis (femtoliter)
  3. l tit l h i t id tif analytitcal chemistry

    = identify and quantify molecules and quantify molecules largest impact in near future: stem cells, g p , cryobiological librairies, tissue engineering, organ engineering completely new medicine organ engineering, completely new medicine
  4. l tit l h i t id tif analytitcal chemistry

    = identify and quantify molecules and quantify molecules example: cell culture p 99% of protein mass is < 20 proteins 1% is the remaining 100 000 1% is the remaining 100,000  difficult
  5. vision • identify and quantify all compounds in a mixture

    („...omics“) • as a function of time (monitoring) ... as a function of time (monitoring) • ... as a function of space (imaging)
  6. information t t vision content „...ome“ complex mixture mixture 1

    d ti l mixture time 1 times 1 location 1 compound continuously 1/s 1/min 1d 2d 3d space 3d
  7. How can we do it ? What will it cost

    ? h i d i k What time does it take ?
  8. why miniaturize why miniaturize volume of 1µL 1nL 1pL (1mm)3

    (100µm)3 (10µm)3 is a cube of 600,000,000 600,000 600 # molecules (1nM solution) 25 / cm2 2500 / cm2 250 ,000/ cm2 # volumes In array 17 min 10s 100ms diffusion time 1.5 /min / cm2 250 /s / cm2 2,500,000 /s / cm2 # reactions (diffusion controlled) (diffusion controlled)
  9. How about 100 nm scale (cube)? •Limitation to >mM concentration

    •Limitation to molecular weight < 100 000 100,000 •Time scale is fast enough at 1 um g scale
  10. What do we have now? What do we have now?

    [example 1] [example 1] • Electrophoresis chips - Caliper Electrophoresis chips Caliper, Agilent, Hitachi, Shimadzu etc. i l d f A f • mainly used for DNA fragment sizing • protein separations bi • bioassays
  11. 10 fold miniaturization 100 x faster separation p 1000 x

    smaller volume 10 x lower reagent consumption
  12. electrophoresis p c e [ a r b . u

    n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8
  13. nano channels & single molecules 80 x 80 nm channel

    bulk DNA L.C.Campbell, M.J.Wilkinson, A.Manz, P.Camilleri, C.J.Humphreys
  14. What do we have now? What do we have now?

    [example 2] [example 2] • Reactor chips - Upchurch, Ehrfeld etc. etc. • Mainly used for solvent di t i h t h gradients in chromatography • Chemical synthesis y • Bioassays
  15. F. G. Bessoth, Dissertation, Imperial College, 2000. F. G. Bessoth,

    A. J. deMello, A. Manz, Anal. Commun., 1999, 36, 6, 213-215.
  16. chemical reactor Micromixer chip / PTFE interface PTFE interface Inlet

    capillaries Syringes Injection loop Rheodyne injection valve Injection loop outlet capillary
  17. H R1 O M OH Cl- R1 Multicomponent Chemistries: The

    Ugi Reaction N+ H H R R2 Cl- H H MeOH N+ Cl H2 O R2 R1/R2 = -CH2 (CH2 )3 CH2 - + + Piperidinium cation Formaldehyde 0oC R3 R /R CH2 (CH2 )3 CH2 Piperidine hydrochloride Piperidinium cation y (1) (2) (3) N R4 C R3 R3 R3/R4 = -CH2 (CH2 )4 CH2 - R1 N R4 H2 O R1 N N R4 O + 2 ( 2 )4 2 Cyclohexyl isocyanide (4) N R2 R2 Nitrilium intermediate -Dialkylacetamide N-Cyclohexyl-2-piperidin-1-yl-acetamide Nitrilium intermediate (5) (6)
  18. Simultaneous Observation of Reactants, Intermediates, Products and By-products 20 L

    i 1 20 Lmin-1 50 nL injection loop Room temperature
  19. Set-up for NMR measurement NMR Detection coil Micromixer (200m i.d.)

    Syringe pumps y g p p 250m i.d. 75m i.d.
  20. Hi 68 Tyr59 A His68 N N A 10 L/min

    (24sec) N N A 40 L/min (6sec) A (6sec) Sweedler group, group, Univ. of Illinois
  21. DNA hybridisation assays DNA hybridisation assays contribution to Fluorescence contribution

    to Fluorescence Intercalating dye alone low DNA oligomers low Oligomer dimers medium dsDNA high dsDNA high
  22. influence of DNA sequence on influence of DNA sequence on

    kinetics kinetics Order: t hi 1 matching, 1 mismatch, 2 mismatches Sequence-dependent responses from two different experiments.
  23. microfluidic DNA assays 1 d t d i i •

    1 second to decision • no complicated surface chemistry • no complicated surface chemistry • sensitivity 100-200nM sensitivity 100 200nM • could be competing with DNA arrays
  24. What would I address? What would I address? [example 1]

    [example 1] protein separations by free-flow electrophoresis y p … isoelectric focusing
  25. IEF hi IEF chip • 36 x 20 um inlet

    channels • 72 x 20 um outlet channels h id 108 4 h l • each side 108 x 4 um channels • separation bed 12.2 x 4.1 mm p – 15,552 posts 30 x 30 um – 30 x 30 um
  26. comparison p FFE FFE c e [ a r b

    . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . c e [ a r b . u n i t s ] 1 2 3 4 c y c l e # t 7 s s y n c h r . f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 f l u o r e s c e n 0 4 0 8 0 1 2 0 1 6 0 5 6 7 8 CE
  27. I l t i f i Isoelectric focusing • charge

    of protein molecule depends on pH g p p p • low pH (acidic): protein is cation hi h H (b i ) t i i i • high pH (basic): protein is anion • generate a pH gradient across electric field g p g – ions move until overall charge is zero isoelectric point is different for each protein – isoelectric point is different for each protein
  28. IEF f f i i l IEF proof of principle

    12 mm angiotensin I, 1.75 kV, 10 uL/min g o e s , .75 V, 0 u / 4 mm = 500 ms 4 mm = 500 ms 4 mm 0 mm
  29. IEF t i IEF - proteins angiotensin I, 1.75 kV,

    10 uL/min g o e s , .75 V, 0 u /
  30. IEF hi IEF chip • volume 240 nL plus wells

    p • at 10 uL/min 1 4 d (ti t i f ti ) – 1.4 seconds (time to information) • preconcentration 100 - 400x
  31. What would I address? What would I address? [example 2]

    [example 2] air quality monitor by plasma emission spectroscopy y p p py gas chromatography
  32. detector plasma emission detector volume 50 L p 50 nL

    J.C.T.Eijkel, H.Stoeri, A.Manz, J. Anal. At. Spectrom. 15, 297-300 p , (2000)
  33. plasma emission CH2 Cl2 p 4000 4500 CH2 Cl2 CH

    He He H He 3500 4000 Cl 2500 3000 n s ity (A U ) 2000 is s io n In te n CCl C/C2 1000 1500 Em 0 500 C2 0 200 300 400 500 600 700 800 900 Wavelength (nm)
  34. calibration for methane calibration for methane J.C.T.Eijkel, H.Stoeri, A.Manz Anal.

    Chem. 71, 2600-2606 (1999) d i li i 2 10 14 / C • detection limit 2·10-14 g/s C 4 U. 104 ound / A. 1000 us backgro 100 nsity minu sion inten 3*Noise 10 1 10 100 1000 emiss CH 4 concentration / ppm
  35. CONCLUSIONS • Reactions and separations benefit from h t ti

    l i i h shorter timescales, micro is enough • Detection schemes usually suffer, but to y different extents, nano is quite difficult • Integration / small volumes advantageous, Integration / small volumes advantageous, below 1 nL doesn’t matter • More commercial products in near future • More commercial products in near future, but micro scale
  36. Acknowledgment g my Imperial College team my new ISAS team

    Joachim Franzke Norbert Jakubowski Jan Eijkel Gareth Jenkins Norbert Jakubowski Philip Day Yi Xu Chao-Xuan Zhang Valerie Spikmans Martin Heule Jörg Baumbach Volker Deckert g Michael Mitchell Fi B h Dirk Janasek L C b ll Roland Hergenröder N b E Fiona Bessoth Lucy Campbell Norbert Esser Kay Niemax, Prof.
  37. Acknowledgment funding g Glaxo SmithKline (UK) Glaxo SmithKline (UK) AstraZeneca

    (UK) EU research grant Casect Ltd. (UK) ( ) Swiss National Science Foundation (Switzerland) EPSRC grant (UK) Leopoldina (Germany)